Market will rally through y/e and CELG is head to $179-$180. William Blair just raise LT to $17 EPS - company is at $13-14 EPS....29 other analysts have to raise..ASH will be big for CELG. JPM copany raises that $13-$14. BUY and avg up - DO NOT SELL
Rather significant mistake selling now instead of mid Jan imo. Major positive detail at ASH on MM-020, then chase for performance on winners into yr end - and then a MAJOR rise in guidance at JP Morgan early Jan. Buy
Apremilast will be cheaper than biologics - and is oral will require no injection or office visit. It does not have the infection, tuberculosis or leukemia risk of Enbrel or Humira and works better before dmards like methotrexate with their horrible side effects. HALF the biologic patients say the drugs side effects ARE WORSE THAN THE DISEASE.